@article{gibbs:hal-01239810,
TITLE = {SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 \+/-\ bevacizumab (bev) versus mFOLFOX6 + selective internal radiation therapy (SIRT) \+/-\ bev in patients (pts) with metastatic colorectal cancer (mCRC)},
AUTHOR = {Gibbs, Peter and Hazel, Guy A. Van and Heinemann, Volker and Sharma, Navesh K. and Findlay, Michael P. N. and Ricke, Jens and Peeters, Marc and Perez, David and Robinson, Bridget and Strickland, Andrew and Ferguson, Tom and Rodrigez, Javier and Kroening, Hendrik and Wolf, Ido and Ganju, Vinod and Walpole, Euan and Boucher, Eveline and Tichler, Thomas and Gebski, Val and van Buskirk, Mark},
URL = {https://univ-rennes.hal.science/hal-01239810},
JOURNAL = {Asia-Pacific Journal of Clinical Oncology},
HAL_LOCAL_REFERENCE = {WOS:000364320800021},
PUBLISHER = {Wiley},
VOLUME = {11},
NUMBER = {Special issue: ASCO Annual Meeting},
PAGES = {68--69},
YEAR = {2015},
HAL_ID = {hal-01239810},
HAL_VERSION = {v1},
}